Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Forest Laboratories Holdings Ltd. et al v. Apotex Corp. et al
Case Number:
1:13-cv-01602
Court:
Nature of Suit:
Judge:
Firms
- Duane Morris
- Eckert Seamans
- Heyman Enerio
- Morris James
- Morris Nichols
- Phillips McLaughlin
- Potter Anderson
- Shaw Keller
- Smith Katzenstein
- Whiteford Taylor
- Young Conaway
Companies
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Forest Laboratories Inc.
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Mylan NV
- Par Pharmaceutical Cos. Inc.
- Ranbaxy
- Royalty Pharma
Sectors & Industries:
-
July 12, 2016
Mylan Infringed Forest's Savella Drug Patents, Judge Rules
A Delaware federal judge ruled Monday that Mylan Inc.'s attempt to make a generic version of fibromyalgia treatment Savella infringed three patents held by Forest Laboratories Holdings Ltd. and that the patents' asserted claims are valid.
-
January 21, 2016
Apotex Exits Forest's Patent Suit Over Generic Savella
Forest Laboratories Inc. has agreed to drop its claims that Apotex Inc. infringed three patents covering fibromyalgia treatment Savella after the generics manufacturer agreed that its application to the U.S. Food and Drug Administration to create generic versions of the drug was a technical act of infringement.
-
September 24, 2013
Forest Sues Mylan, Others To Block Generic Savella
Forest Laboratories Inc. filed six separate lawsuits Monday against a slew of generic-drug makers including Mylan Inc. and Apotex Corp., alleging their attempts to create generic versions of fibromyalgia treatment Savella infringe its patents.